Company Profile

CaliberMRI Inc (AKA: CMRI~QalibreMD Inc~Qalibre MD Inc~QMD)
Profile last edited on: 10/11/2023      CAGE: 7XL23      UEI: CK99A8JTWJ15

Business Identifier: MRI imaging phantoms, quantitative MRI (qMRI), diffusion phantoms, qCal-MR QA/QC software, MRI scan data standardization, MRI research library, Global Standardization Platform for qMRI
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4909 Nautilus Court North Suite 121
Boulder, CO 80301
   (720) 828-7674
Location: Single
Congr. District: 02
County: Boulder

Public Profile

CaliberMRI, Inc. (DBA QalibreMD) is a startup spun out of the SBIR-involved firm High Precision Devices and structured around commercializing quantitative MRI technology facilitating the development of faster (and more accurate) MRI scans. QalibreMD's standards are intended to provide a baseline for measuring quantitative imaging biomarkers. From the premsie that for MRI results to be of greatest benefit to researchers and patients, the results must be accurate and reproducible - requiring tandardization across MRI sites and vendor scanners is essential for comparing results and improving patient outcomes.QDeveloped collaboratively with the ISMRM, QIBA/RSNA and NIST, the QallibreMD effort is to provide a ground truth baseline for measuring quantitative imaging biomarkers. With a broad range of patented multiparametric parameters traceable to NIST, these standards are intended to deliver rigor and relevance to medical research and patient care.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Bill Hollander -- Founder & CEO

  Debi Holmes -- Financial Controller

  Chamni Jayarathna -- Analytical Research Chemist

  Todor Karaulanov -- Chief Scientist

  Kevin Miller -- Director of Business Development

  Callie Weiant -- President, Chief Revenue Officer